<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">13887</article-id><article-id pub-id-type="doi">10.7554/eLife.13887</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Secretion of protein disulphide isomerase AGR2 confers tumorigenic properties</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-47923"><name><surname>Fessart</surname><given-names>Delphine</given-names></name><aff><institution>Université de Bordeaux</institution>, <addr-line><named-content content-type="city">Bordeaux</named-content></addr-line>, <country>France</country><email>delphine.fessart@yahoo.fr</email></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49030"><name><surname>Domblides</surname><given-names>Charlotte</given-names></name><aff><institution>Université de Bordeaux</institution>, <addr-line><named-content content-type="city">Bordeaux</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55736"><name><surname>Avril</surname><given-names>Tony</given-names></name><aff><institution content-type="dept">Oncogenesis, Stress, Signaling</institution>, <institution>University of Rennes 1</institution>, <addr-line><named-content content-type="city">Rennes</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55737"><name><surname>Eriksson</surname><given-names>Leif A</given-names></name><aff><institution content-type="dept">Department of Chemistry and Molecular Biology</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Göteborg</named-content></addr-line>, <country>Sweden</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49031"><name><surname>Begueret</surname><given-names>Hugues</given-names></name><aff><institution>Hôpital Haut-Lévêque</institution>, <addr-line><named-content content-type="city">Bordeaux</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49032"><name><surname>Pineau</surname><given-names>Raphael</given-names></name><aff><institution>Université de Bordeaux</institution>, <addr-line><named-content content-type="city">Bordeaux</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55738"><name><surname>Malrieux</surname><given-names>Camille</given-names></name><aff><institution>Université de Bordeaux</institution>, <addr-line><named-content content-type="city">Bordeaux</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49033"><name><surname>Dugot-Senant</surname><given-names>Nathalie</given-names></name><aff><institution>Université de Bordeaux</institution>, <addr-line><named-content content-type="city">Bordeaux</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49034"><name><surname>Lucchesi</surname><given-names>Carlo</given-names></name><aff><institution>Bergonié Cancer Institute</institution>, <addr-line><named-content content-type="city">Bordeaux</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49035"><name><surname>Chevet</surname><given-names>Eric</given-names></name><aff><institution content-type="dept">Oncogenesis, Stress, Signaling</institution>, <institution>University of Rennes 1</institution>, <addr-line><named-content content-type="city">Rennes</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49036"><name><surname>Delom</surname><given-names>Frederic</given-names></name><aff><institution>Université de Bordeaux</institution>, <addr-line><named-content content-type="city">Bordeaux</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-17221"><name><surname>Ivaska</surname><given-names>Johanna</given-names></name><role>Reviewing editor</role><aff><institution>University of Turku</institution>, <country>Finland</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>05</month><year>2016</year></pub-date><elocation-id>e13887</elocation-id><supplementary-material><ext-link xlink:href="elife-13887-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>17</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>28</day><month>05</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Fessart et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Fessart et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>The extracellular matrix (ECM) plays an instrumental role in determining the spatial orientation of epithelial polarity and the formation of lumens in glandular tissues during morphogenesis. Here, we show that the Endoplasmic Reticulum (ER)-resident protein anterior gradient-2 (AGR2), a soluble protein-disulfide isomerase involved in ER protein folding and quality control, is secreted and interacts with the ECM. Extracellular AGR2 (eAGR2) is a microenvironmental regulator of epithelial tissue architecture, which plays a role in the preneoplastic phenotype and contributes to epithelial tumorigenicity. Indeed, eAGR2, is secreted as a functionally active protein independently of its thioredoxin-like domain (CXXS) and of its ER-retention domain (KTEL), and is sufficient, by itself, to promote the acquisition of invasive and metastatic features. Therefore, we conclude that eAGR2 plays an extracellular role independent of its ER function and we elucidate this gain-of-function as a novel and unexpected critical ECM microenvironmental pro-oncogenic regulator of epithelial morphogenesis and tumorigenesis.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal procedures met the European Community Directive guidelines (Agreement B33-522-2/ Number DIR 1322) and were approved by the ethical committee from Bordeaux University.</p></fn><fn fn-type="other"><p>Human subjects: Samples of human lung cancer tissues were obtained from the Haut-Leveque University Hospital (Bordeaux, France) and reviewed by expert pathologist in the field (H. Begueret). These procedures were approved by the Institutional Review Board at Haut-Leveque (NFS96900 Certification).</p></fn></fn-group></back></article>